Dolat Algotech Limited (DOLATALGO.NS)
INR 85.68
(2.04%)
INR 85.68
(2.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 332.03 Million | 787 Million | 1.4 Billion | 1.88 Billion | 1.64 Billion | 411.63 Million |
| Net Income | 1.57 Billion | 1.62 Billion | 2.3 Billion | 2.01 Billion | 1.01 Billion | 774.99 Million |
| Depreciation & Amortization | 11.66 Million | 7.12 Million | 3.44 Million | 2.88 Million | 175 Thousand | 49.66 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.33 Billion | 93.69 Million | -28.23 Million | 574.62 Million | 734.06 Million | -222.95 Million |
| Other non-cash items | 105.95 Million | -939.32 Million | -869.87 Million | -707.38 Million | -108.51 Million | -140.44 Million |
| Investing Cash Flow | -120.18 Million | -1.18 Billion | -965.16 Million | -3.62 Billion | -598.7 Million | - |
| Investments in PPE | -34.96 Million | -8.43 Million | -10.8 Million | -4.57 Million | -3.7 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -87.4 Million | -1.54 Billion | -1.24 Billion | -3.82 Billion | -595 Million | - |
| Sales/Maturities of investments | 2.18 Million | - | - | - | - | - |
| Other Investing Activities | 367.66 Million | 376.06 Million | 293.14 Million | 197.42 Million | -595 Million | - |
| Financing Cash Flow | -46.72 Million | -45.12 Million | -36.49 Million | -29.69 Million | -81.77 Million | -71.05 Million |
| Debt repayment | - | - | - | - | -35.9 Billion | -17.47 Billion |
| Dividends payments | -44 Million | -44 Million | -35.2 Million | -26.4 Million | -21.21 Million | -21.21 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.72 Million | -1.12 Million | -1.29 Million | -3.29 Million | 35.84 Billion | 17.42 Billion |
| Accounts receivables | -1.06 Billion | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.33 Billion | 93.69 Million | -28.23 Million | 574.62 Million | 734.06 Million | -222.95 Million |
| Cash at beginning of period | 11.23 Million | 450.24 Million | 42.11 Million | 1.81 Billion | 856.04 Million | 517.46 Million |
| Cash at end of period | 72.75 Million | 11.23 Million | 450.24 Million | 42.11 Million | 1.81 Billion | 858.05 Million |
| Capital Expenditure | -34.96 Million | -8.43 Million | -10.8 Million | -4.57 Million | -3.7 Million | - |
| Effect of forex changes on cash | - | - | - | -290.91 | -0.35 | - |
| Net cash flow / Change in cash | 61.52 Million | -439.01 Million | 408.13 Million | -1.77 Billion | 960.34 Million | 340.58 Million |
| Free Cash Flow | 297.07 Million | 778.57 Million | 1.39 Billion | 1.87 Billion | 1.63 Billion | 411.63 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 716.79 Million | 680.51 Million | 1.57 Billion | 414.43 Million | 349.67 Million | 128.68 Million |
| Depreciation & Amortization | - | - | 11.66 Million | 3.17 Million | 4.13 Million | 1.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -1.33 Billion | - | - | - |
| Other non-cash items | -716.79 Million | -680.51 Million | 105.95 Million | -414.43 Million | -349.67 Million | -128.68 Million |
| Investing Cash Flow | - | - | -120.18 Million | - | 127.47 Million | - |
| Investments in PPE | - | - | -34.96 Million | - | -16.27 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -87.4 Million | - | - | - |
| Sales/Maturities of investments | - | - | 2.18 Million | - | - | - |
| Other Investing Activities | - | - | 367.66 Million | - | 143.74 Million | - |
| Financing Cash Flow | - | - | -46.72 Million | - | -460 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -44 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -2.72 Million | - | -460 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -1.33 Billion | - | - | - |
| Cash at beginning of period | - | - | 11.23 Million | 26.33 Million | -150 Million | 11.23 Million |
| Cash at end of period | - | - | 72.75 Million | 32.67 Million | 176.33 Million | 14.47 Million |
| Capital Expenditure | - | - | -34.96 Million | - | -16.27 Million | - |
| Effect of forex changes on cash | - | - | - | - | 11.24 Million | - |
| Net cash flow / Change in cash | - | - | 61.52 Million | 6.34 Million | 326.33 Million | 3.24 Million |
| Free Cash Flow | - | - | 297.07 Million | 6.34 Million | 21.81 Million | 3.24 Million |
PCCWY
IQAI
PSYC
FNEVY
1427
8699